131 results
Page 5 of 7
6-K
EX-10.1
5p0dkf
12 May 20
Current report (foreign)
12:04pm
6-K
EX-4.1
367bu5 1va4abm35gb
12 May 20
Current report (foreign)
12:04pm
424B5
01u9uvon1fv rg
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-10.1
4w0e92hp41 kc
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-4.1
w256s wc6abjcwovn
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
0p8oflpv176sv
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
EX-99.1
1lk5 jpdp
26 Mar 20
VBL Therapeutics Announces Positive Outcome of the Interim Analysis in the OVAL Phase 3 Ovarian Cancer Pivotal Study
8:08am
6-K
0bx3ef89xrgzyb
14 Nov 19
Current report (foreign)
7:01am
6-K
EX-99.2
95vhx2 mgjr9vcmkbk
1 Nov 19
Current report (foreign)
4:15pm
6-K/A
782e 8v91l9o0m3e5h
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
zia3bso
13 Aug 19
Current report (foreign)
7:00am
S-8
yw5 gjv3g
27 Jun 19
Registration of securities for employees
4:06pm
6-K
EX-10.1
557ek p7e5
17 May 19
Current report (foreign)
5:20pm
424B5
24f98lwflv6rwnp
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
l1k34juaj0l9c
15 May 19
Current report (foreign)
7:00am
6-K
ewpl2x
20 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.2
0d3ji24 fl
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am